SCHEMBL23696963

SCHEMBL23696963

CCOC(=O)COc1c(Cl)cccc1C=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ NLRP3 Q96P20 1/20 0.50
▸ USP2 O75604 1/20 0.48
▸ LMNA P02545 4/20 0.46
▸ MAPT P10636 4/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ POLB P06746 1/20 0.46
▸ GAA P10253 2/20 0.45
▸ L3MBTL1 Q9Y468 3/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ NPSR1 Q6W5P4 3/20 0.44
▸ HPGD P15428 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ S1PR4 O95977 1/20 0.44
▸ ITGA4 P13612 1/20 0.44
▸ S1PR1 P21453 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10410458 0.87 KMT2A (0.61) ALDH1A1NLRP3USP2LMNAMAPT
SCHEMBL28921813 0.83 ALDH1A1 (0.60) ALDH1A1CYP1A2CYP2C19NLRP3USP2
SCHEMBL20068038 0.83 ALDH1A1 (0.56) ALDH1A1CYP1A2CYP2C19USP2LMNA
SCHEMBL74619 0.82 ALDH1A1 (0.65) ALDH1A1CYP1A2CYP2C19USP2LMNA
SCHEMBL1253929 0.82 L3MBTL1 (0.44) ALDH1A1LMNAKMT2AGAAL3MBTL1
SCHEMBL11781754 0.82 ALDH1A1 (0.57) ALDH1A1CYP1A2CYP2C19NLRP3USP2
SCHEMBL18095828 0.81 KMT2A (0.72) KMT2AKDM4EHTTPTPN7PTPN12
SCHEMBL1950817 0.80 USP2 (0.56) ALDH1A1CYP1A2CYP2C19USP2LMNA
SCHEMBL1299322 0.78 ERN1 (0.41) ALDH1A1LMNAKMT2AGAAL3MBTL1
SCHEMBL6473593 0.78 L3MBTL1 (0.41) ALDH1A1LMNAMAPTKMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210230123-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2021-07-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210230123-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 ALDH1A1 171/4885CYP1A2 1119/4885CYP2C19 1550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback